These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34655417)

  • 1. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.
    Mao C; Ding Y; Xu N
    Mol Cell Biochem; 2022 Jan; 477(1):213-223. PubMed ID: 34655417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of prostate cancer by analyzing oxidative stress in human seminal plasma: developing unsophisticated tools for noninvasive prostate cancer diagnosis.
    Barrio-Muñoz M; Abad-Gairín C; Amengual-Guedán JM; Prats-López J
    Eur J Cancer Prev; 2016 Nov; 25(6):518-23. PubMed ID: 26633164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels.
    Ferre-Giraldo A; Castells M; Sánchez-Herrero JF; López-Rodrigo O; de Rocco-Ponce M; Bassas L; Vigués F; Sumoy L; Larriba S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.
    Neuhaus J; Schiffer E; von Wilcke P; Bauer HW; Leung H; Siwy J; Ulrici W; Paasch U; Horn LC; Stolzenburg JU
    PLoS One; 2013; 8(6):e67514. PubMed ID: 23826311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
    Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semen AMACR protein as a novel method for detecting prostate cancer.
    Etheridge T; Straus J; Ritter MA; Jarrard DF; Huang W
    Urol Oncol; 2018 Dec; 36(12):532.e1-532.e7. PubMed ID: 30337219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteomics of prostate cancer exosomes.
    Drake RR; Kislinger T
    Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients.
    Zenzmaier C; Heitz M; Klocker H; Buck M; Gardiner RA; Berger P
    J Transl Med; 2011 Nov; 9():193. PubMed ID: 22071168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs as biomarkers in prostate cancer.
    Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
    Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers.
    Ponti G; Maccaferri M; Manfredini M; Cotugno M; Pellacani G; Conti A; Micali S; Mandrioli M; Tomasi A
    Med Hypotheses; 2018 May; 114():69. PubMed ID: 29602469
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers.
    Jin W; Fei X; Wang X; Song Y; Chen F
    Mediators Inflamm; 2020; 2020():8730608. PubMed ID: 32454797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for prostate cancer.
    Schiffer E
    World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
    Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
    Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the main PSA glycoforms in aggressive prostate cancer.
    Gratacós-Mulleras A; Duran A; Asadi Shehni A; Ferrer-Batallé M; Ramírez M; Comet J; de Llorens R; Saldova R; Llop E; Peracaula R
    Sci Rep; 2020 Nov; 10(1):18974. PubMed ID: 33149259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging biomarkers in the detection and prognosis of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2015 Jun; 53(7):963-73. PubMed ID: 25581761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.